Form 4: Edwards Lifesciences Executive Stock Disposition

Daveen Chopra, CVP of TMTT & Surgical at Edwards Lifesciences, reported the disposition of 282 shares of common stock.

Summary

• Daveen Chopra, CVP of TMTT & Surgical at Edwards Lifesciences Corp (EW), disposed of 282 shares of common stock.
• The transaction occurred on May 3, 2026, at a price of $83.98 per share.
• The disposition was executed via code 'F', indicating the payment of tax liability by delivering or withholding securities.
• Following this transaction, the reporting person maintains beneficial ownership of 31,919 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as the transaction is a mandatory tax-related withholding rather than a discretionary sale.

Positives

• The transaction was a routine tax withholding event rather than a discretionary open-market sale, suggesting no change in long-term confidence.

Negatives

• Reduction in the total number of shares held by a key executive.

Risks

• None identified; this is a standard regulatory disclosure regarding executive compensation tax obligations.

Future Outlook

Not applicable as this is a retrospective disclosure of a change in beneficial ownership.

Industry Context

StockSavvy.ai notes that routine tax-related share withholdings by executives are standard industry practice and generally do not signal a change in corporate strategy or executive sentiment regarding company performance.

Comparison to Industry Standards

• The transaction aligns with standard executive compensation and tax compliance practices observed across the medical device sector.

Stakeholder Impact

• Minimal impact on shareholders as the transaction is a routine administrative tax event.

Next Steps

• None

Key Dates

Keywords

Edwards Lifesciences, EW, Form 4, Insider Trading, Executive Compensation, Stock Disposition